Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease
Filiz Canpolat MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorMehmet Ünver MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorFatma Eskioğlu MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorŞebnem Kösebalaban MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorSelda Pelin Kartal Durmazlar MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorFiliz Canpolat MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorMehmet Ünver MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorFatma Eskioğlu MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorŞebnem Kösebalaban MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorSelda Pelin Kartal Durmazlar MD
From the Dermatology Clinic and Department of Biochemistry and Clinical Biochemistry, Social Security Training Hospital, Ankara, Turkey
Search for more papers by this authorAbstract
Objectives Adenosine deaminase (ADA) is a non-specific marker of the activation of the T cell, which has an important role in the etiology of Behçet's disease (BD). The purpose of this study was to investigate the determination of ADA activity as an index of T-lymphocyte function in BD, which is known to have an T-cell-mediated immune response.
Materials and Methods Adenosine deaminase activities in both serum and erythrocytes were measured in 23 untreated patients with BD and in 20 healthy controls. The patients with BD were divided into two groups: active (n = 10) and inactive (n = 13).
Results When compared with the control group, serum ADA activity was high (P < 0.01) and erythrocyte ADA activity was significantly low (P < 0.01) in BD. Serum ADA activity of active BD was higher than that of inactive BD (P < 0.01), but erythrocyte ADA activity was found to be lower in active BD than inactive BD (P < 0.01).
Comment These findings may provide an additional benefit for the diagnosis of BD and sub-typing of active and inactive BD.
References
- 1 Sakane T, Takeno M, Suzukı N, et al. Behçet's disease. N Engl J Med 1999; 341: 1284–1291.
- 2 Yazıcı H, Yurdakul S, Hamuryudan V. Behçet's syndrome. Curr Opin Rheum 1999; 11: 53–57.
- 3 Lehner T. Immunopathogenesis of Behçet's disease. Ann Med Interne 1999; 150: 483–487.
- 4 Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 1991; 34: 39.
- 5 Mizushima Y. Skin hypersensitivity to streptococcal antigens and the induction of the systemic symptoms by antigens in Behçet's disease: A multicentre study. J Rheumatol 1989; 16: 506.
- 6 Mizushima Y, Matsuda T, Hashi K. Introduction of Behçet's disease symptoms following dental treatment and streptoccal antigen skin test. J Rheumatol 1988; 15: 1029–1030.
- 7 Lehner T. Behçet's Syndrome and auto-immunity. Br J Med 1967; 1: 465.
- 8 Rogers RD, Sams WJ, Shorter RG. Lymphotoxicity in recurrent apthous stomatitis. Lymphotoxicity for oral epithelial cells in recurrent apthous stomatitis and Behçet's syndrome. Arch Dermatol 1974; 109: 361–363.
- 9 Lehner T, Lavery E, Smith R, et al. Association between the 65-kilodalton heat shock protein, streptococus sangius and the corresponding antibodies in Behçet's syndrome. Infect Immun 1991; 59: 1434–1441.
- 10 Jindal S, Dudani AK, Singh B, et al. Primary structure of a human mithocondrial protein homologous to the bacterial and plant chaparonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 1989; 9: 2279.
- 11 Adams A, Harkness RA. Adenosine deaminase activity in thymus and other human tissues. Clin Exp Immunol 1976; 26: 647–649.
- 12 Collazos J, Espana P, Mayo J, et al. Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis. Chest 1998; 114: 432–435.
- 13 Bükülmez G, Akan T, Ciliv G. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. Eur J Dermatol 2000; 10: 274–276.
- 14 Köse K, Yazıcı C, Aşçıoğlu Ö. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease. Clin Biochem 2001; 34: 125–129.
- 15 Söğüt S, Aydın E, Elyas H, et al. The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behçet's disease. Clin Chim Acta 2002; 325: 133–138.
- 16 International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–1080.
- 17 Turan B, Gallati H, Erdi H, et al. Systemic levels of the T-cell regulatory cyokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997; 24: 128–132.
- 18 Lawton G, Bhakta BB, Chamberlain MA, et al. The Behçet's disease activity index. Rheumatol 2004; 43: 73–78.
- 19 Oosthuizen HM, Ungerer JPJ, Bissport SH. Kinetic determination of serum adenosine deaminase. Clin Chem 1993; 39: 2182–2185.
- 20 Mege JL, Dilsen N, Sangudolce V, et al. Over-production of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544–1549.
- 21 Kaklamani VG, Kaklamanis PG. Treatment of Behçet's disease, an update. Semin Arthritis Rheum 2001; 30: 299–312.
- 22 Keser G, Öksel F, Aksu K, et al. Serum neopterin levels in Behcet's syndrome. Clin Rheumatol 2000; 19: 328–329.
- 23 Müler W, Lehner T. Quantitative electron microscopial analysis of leukocyte infiltration in oral ulcers of Behcet's syndrome. Br J Dermatol 1982; 106: 533–544.
- 24 Köse K, Doğan P, Aşçıoğlu M, et al. Oxidative stress and antioxidant defences in plasma of patients with Behçet's disease. Tohoku J Exp Med 1995; 176: 239–248.
- 25 Giblett ER, Anderson JE, Cohen F, et al. Adenosine deaminase deficiency in two patients with severe impaired cellular immunity. Lancet 1972; 2: 1067–1069.
- 26 Sasaki T, Nakajima H. Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. J Am Acad Dermatol 1992; 27: 411–414.
- 27 Koizomi H, Tomizawa K, Tonaka H, et al. Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides. J Dermatol 1993; 20: 394–397.
- 28 Hitoglou S, Hatzistilianou M, Gougoustamou D, et al. Adenosine deaminase activity and its iso-enzymes pattern in patients with juvenile rheumatoid arthritis and systemic lupus erytematosus. Clin Rheumatol 2001; 20: 411–416.
- 29 Erkılıç K, Evereklioğlu C, Cemken M, et al. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, super-oxide dismutase and glutathione peroxidase in patients with Behcet's disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 2003; 12: 107–116.
- 30 Köse K, Yazıcı C, Çambay N, et al. Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease. Tohoku J Exp Med 2002; 197: 9–16.
- 31 Örem A, Efe H, Deger O, et al. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. Dermatol Sci 1997; 16: 11–16.
- 32 Pfafferot C, Meielman HJ, Hochstein P. The effect of malondialdehyde on erythrocyte deformability. Blood 1982; 59: 12–15.
- 33 Jackson EK, Mi Z, Koehler MT, et al. Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther 1996; 279: 1250–1260.
Citing Literature
